{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:17:14Z","timestamp":1783387034203,"version":"3.54.6"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"B Braun Korea"},{"name":"Boryung Pharmaceutical"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1245\/s10434-022-11582-5","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:03:09Z","timestamp":1648062189000},"page":"5084-5091","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Safety and Efficacy of Intraperitoneal Paclitaxel Plus Intravenous Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX) for Gastric Cancer with Peritoneal Metastasis"],"prefix":"10.1245","volume":"29","author":[{"given":"So Hyun","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa-Hong","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangjun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Jeong","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Suk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Suhk","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keun-Wook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Seung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,23]]},"reference":[{"issue":"3","key":"11582_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"Ca Cancer J Clin."},{"issue":"32","key":"11582_CR2","doi-asserted-by":"publisher","first-page":"52307","DOI":"10.18632\/oncotarget.10740","volume":"7","author":"M Riihim\u00e4ki","year":"2015","unstructured":"Riihim\u00e4ki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. Metastatic spread in patients with gastric cancer. Oncotarget. 2015;7(32):52307\u201316. https:\/\/doi.org\/10.18632\/oncotarget.10740.","journal-title":"Oncotarget."},{"issue":"3","key":"11582_CR3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, Gestel YR, Ramshorst B, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134(3):622\u20138. https:\/\/doi.org\/10.1002\/ijc.28373.","journal-title":"Int J Cancer."},{"issue":"10","key":"11582_CR4","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/jjco\/hyt114","volume":"43","author":"K Shirao","year":"2013","unstructured":"Shirao K, Boku N, Yamada Y, et al. Randomized phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106). Jpn J Clin Oncol. 2013;43(10):972\u201380. https:\/\/doi.org\/10.1093\/jjco\/hyt114.","journal-title":"Jpn J Clin Oncol."},{"issue":"5","key":"11582_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/s1470-2045(03)01074-x","volume":"4","author":"M Markman","year":"2003","unstructured":"Markman M. Intraperitoneal antineoplastic drug delivery: rationale and results. Lancet Oncol. 2003;4(5):277\u201383. https:\/\/doi.org\/10.1016\/s1470-2045(03)01074-x.","journal-title":"Lancet Oncol."},{"issue":"Suppl 1","key":"11582_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10120-016-0662-9","volume":"20","author":"D Kobayashi","year":"2017","unstructured":"Kobayashi D, Kodera Y. Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis. Gastric Cancer. 2017;20(Suppl 1):111\u201321. https:\/\/doi.org\/10.1007\/s10120-016-0662-9.","journal-title":"Gastric Cancer."},{"issue":"1","key":"11582_CR7","first-page":"1","volume":"62","author":"RL Dedrick","year":"1978","unstructured":"Dedrick RL, Myers CE, Bungay PM, DeVita VT. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep. 1978;62(1):1\u201311.","journal-title":"Cancer Treat Rep."},{"issue":"6","key":"11582_CR8","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","volume":"18","author":"XJ Yang","year":"2011","unstructured":"Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18(6):1575\u201381. https:\/\/doi.org\/10.1245\/s10434-011-1631-5.","journal-title":"Ann Surg Oncol."},{"key":"11582_CR9","doi-asserted-by":"publisher","DOI":"10.1159\/000516959","author":"K Ukegjini","year":"2021","unstructured":"Ukegjini K, Putora PM, Guidi M, et al. Pressurized intraperitoneal aerosol chemotherapy-related clinical trials in the treatment of peritoneal metastases. Oncology. 2021. https:\/\/doi.org\/10.1159\/000516959.","journal-title":"Oncology."},{"issue":"19","key":"11582_CR10","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1200\/jco.2018.77.8613","volume":"36","author":"H Ishigami","year":"2018","unstructured":"Ishigami H, Fujiwara Y, Fukushima R, et al. Phase III trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC Trial. J Clin Oncol. 2018;36(19):1922\u20139. https:\/\/doi.org\/10.1200\/jco.2018.77.8613.","journal-title":"J Clin Oncol."},{"key":"11582_CR11","doi-asserted-by":"publisher","unstructured":"Lin R, Chen Y, Zhu J, et al. POF (paclitaxel plus FOLFOX) versus IP PAC (intraperitoneal paclitaxel plus FOLFOX) versus FOLFOX as a first-line treatment in advanced gastric cancer (AGC): update from a multicenter, randomized phase II trial, FNF-004 trial. J Clin Oncol. 2019;37(15_suppl):4035-4035.:https:\/\/doi.org\/10.1200\/jco.2019.37.15_suppl.4035","DOI":"10.1200\/jco.2019.37.15_suppl.4035"},{"key":"11582_CR12","unstructured":"CTCAE v5. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf. Accessed August 10, 2021."},{"key":"11582_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Liti\u00e8re S, de Vries E, et al. RECIST 1.1\u2014Update and clarification: From the RECIST committee. Eur J Cancer. 2016;62:132\u20137. https:\/\/doi.org\/10.1016\/j.ejca.2016.03.081.","journal-title":"Eur J Cancer."},{"issue":"2","key":"11582_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1515\/pp-2016-0011","volume":"1","author":"W Solass","year":"2016","unstructured":"Solass W, Sempoux C, Detlefsen S, Carr NJ, Bibeau F. Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS). Pleura Peritoneum. 2016;1(2):99\u2013107. https:\/\/doi.org\/10.1515\/pp-2016-0011.","journal-title":"Pleura Peritoneum."},{"issue":"6","key":"11582_CR15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00280-002-0439-1","volume":"49","author":"P Marchettini","year":"2002","unstructured":"Marchettini P, Stuart AO, Mohamed F, Yoo D, Sugarbaker PH. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model. Cancer Chemoth Pharm. 2002;49(6):499\u2013503. https:\/\/doi.org\/10.1007\/s00280-002-0439-1.","journal-title":"Cancer Chemoth Pharm."},{"key":"11582_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-1247-5_4","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Peritoneal carcinomatosis: principles of management. Canc Treat. 1996. https:\/\/doi.org\/10.1007\/978-1-4613-1247-5_4.","journal-title":"Canc Treat."},{"issue":"3","key":"11582_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/nejmoa1708618","volume":"378","author":"WJ van Driel","year":"2018","unstructured":"van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378(3):230\u201340. https:\/\/doi.org\/10.1056\/nejmoa1708618.","journal-title":"N Engl J Med."},{"issue":"2","key":"11582_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1245\/s10434-006-9182-x","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Black D, Savady R, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for Pseudomyxoma peritonei. Ann Surg Oncol. 2007;14(2):484\u201392. https:\/\/doi.org\/10.1245\/s10434-006-9182-x.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"11582_CR19","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","volume":"17","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Arvieux C, et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17(9):2370\u20137. https:\/\/doi.org\/10.1245\/s10434-010-1039-7.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"11582_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12957-019-1761-y","volume":"17","author":"Z Wang","year":"2019","unstructured":"Wang Z, Chen JQ, Liu JL, Tian L. Issues on peritoneal metastasis of gastric cancer: an update. World J Surg Oncol. 2019;17(1):215. https:\/\/doi.org\/10.1186\/s12957-019-1761-y.","journal-title":"World J Surg Oncol."},{"issue":"5","key":"11582_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000209277","volume":"76","author":"H Ishigami","year":"2009","unstructured":"Ishigami H, Kitayama J, Otani K, et al. Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer. Oncology. 2009;76(5):311\u20134. https:\/\/doi.org\/10.1159\/000209277.","journal-title":"Oncology."},{"issue":"1","key":"11582_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/nejmoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006;354(1):34\u201343. https:\/\/doi.org\/10.1056\/nejmoa052985.","journal-title":"N Engl J Med."},{"key":"11582_CR23","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-09388-4","author":"S Saito","year":"2020","unstructured":"Saito S, Yamaguchi H, Ohzawa H, et al. Intraperitoneal administration of paclitaxel combined with S-1 plus oxaliplatin as induction therapy for patients with advanced gastric cancer with peritoneal metastases. Ann Surg Oncol. 2020. https:\/\/doi.org\/10.1245\/s10434-020-09388-4.","journal-title":"Ann Surg Oncol."},{"key":"11582_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.601869","volume":"10","author":"Z Huang","year":"2020","unstructured":"Huang Z, Liu D, Chen X, et al. Deep convolutional neural network based on computed tomography images for the preoperative diagnosis of occult peritoneal metastasis in advanced gastric cancer. Front Oncol. 2020;10:601869. https:\/\/doi.org\/10.3389\/fonc.2020.601869.","journal-title":"Front Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11582-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-11582-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11582-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T20:05:07Z","timestamp":1656619507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-11582-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,23]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["11582"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-11582-5","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,23]]},"assertion":[{"value":"13 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}